Key Findings¹

You are here Home > Key Findings

• In 2024, telehealth accounted for about 10% of outpatient visits nationwide—up sharply from pre-pandemic levels. As health technology advances, emerging hybrid care models combine telehealth with strong patient-clinician communication to deliver quality care.
• Artificial intelligence (AI) has shown promise in improving decision-making and efficiency. Ambient listening tools saved some providers an average of 5.5 hours per week and reduced after-clinic hours by up to 76%.
• By 2025, 90% of hospitals said they would use AI for early diagnosis and remote monitoring. Of hospitals that integrated AI into their systems in 2023, 79% used AI models from electronic health record developers.
• Diabetic ketoacidosis (DKA) admissions have seen a 55% increase over the past decade, especially in individuals under 45 years of age. Early diagnosis and management of DKA are essential to improving outcomes.

• During the 2025 open enrollment period (OEP), nearly 2.9 million more consumers selected or were re-enrolled in an insurance exchange (HIX) plan than during the 2024 OEP, a 13% increase.
• HIX plan selection in Florida and Texas increased by 12.4% and 13.8%, respectively, in 2025, contributing to the nation surpassing the prior year’s enrollment total by 13.4%.
• Overall HIX plan performance on eye exams for diabetes patients (43.9%) lagged all other profiled metrics in 2025—dropping 1.0 percentage point from 44.9% in 2024.
• Across the nation, over half (55.5%) of commercial Type 1 diabetes patients had an A1c >7.0%, with New Mexico seeing the highest percentage of such patients, at 69.7% in 2024.

• Total Medicare Advantage (MA) enrollment increased yet again in 2024, bolstered by HMO and PPO plans. Both Private fee-for-service and Other plan types saw a decrease in enrollment from 2023 to 2024.
• The top 10 largest MA organizations, by enrollment, showed an average decline in star ratings from 2024 to 2025 in two of the five measures profiled.
• Nearly 79% of hospitals participating in the Hospital Readmissions Reduction Program received a penalty in fiscal year (FY) 2025—a 1.0 percentage-point increase from FY 2024.
• Medicare fee-for-service actual costs increased in half of the care settings profiled from 2022 to 2023. ASC costs, for instance, increased by 11.0% in 2023 after a 4.4% rise in 2022.

• National enrollment in Medicaid stood at 111.2% of pre-pandemic levels in December 2024 (79 million lives), steadily declining each month from a peak of 132.5% (95 million lives) in April 2023.
• The percentage of Medicaid enrollees gaining eligibility through expansion-related pathways varies significantly by state, with Oregon registering more than 50% in 2024.

• In 2024, the Medicare average length of stay for the profiled disease states was highest for Type 2 diabetes (5.9 days)—notably 1.4 days longer, on average, than for Type 1 diabetes.
• Among the primary diagnoses profiled, Type 1 diabetes had the highest 2024 Medicare 30-day readmission rate (32.3%), exceeding Type 2 diabetes by more than 11 percentage points.
• The number of PAs was less than half that of NPs with a ratio of 0.48 nationwide in 2023. By state, Mississippi had the lowest ratio (0.07), while Alaska had the highest (0.84).
• In performance year (PY) 2023, the overall average earned shared savings payment to MSSP ACOs reached $6.8 million—a nearly 30% year-over-year increase from PY 2022.

Key Findings1